Gris-Peg 125 mg - 30 Tabs $78
Gris-Peg 125 mg - 60 Tabs $146
Gris-Peg 125 mg - 90 Tabs $208 |
 |
Drug Uses
Gris-PEG is prescribed for the treatment of the following ringworm infections:
Athlete's foot, Barber's itch (inflammation of the facial hair follicles),
Ringworm of the body, Ringworm of the groin and thigh, Ringworm of the nails,
Ringworm of the scalp. Because Gris-PEG is effective only for certain types
of fungal infections, before treatment your doctor may perform tests to identify
the source of infection.
How Taken
Accurate diagnosis of the infecting organism is essential. Adults: Daily
administration of 330 mg (as a single dose or in divided amounts) will give
a satisfactory response. Children: Approximately 3.3 mg per pound of body
weight per day is an effective dose for most children.
Warnings/Precautions
Because Gris-PEG can make you sensitive to light, avoid exposure to intense
natural or artificial sunlight. Notify your doctor if you develop lupus
erythematosus (a form of rheumatism) or a lupus-like condition. Signs and
symptoms of lupus include arthritis, red butterfly rash over the nose and
cheeks, tiredness, weakness, sensitivity to sunlight, and skin eruptions.
If you are being treated with Gris-PEG for an extended period of time, your
doctor should perform regular tests, including periodic monitoring of kidney
function, liver function, and blood cell production. Gris-PEG has not been
proved safe and effective for the prevention of fungal infections. Gris-PEG
may decrease the effectiveness of birth-control pills. Use additional protection
while you are taking Gris-PEG. Men should wait at least 6 months after finishing
therapy with Gris-PEG before they father a child. Women should avoid becoming
pregnant while they are taking the drug.
Missed Dose
Take the missed dose as soon as you remember. If it is almost time for your
next dose, skip the one you missed and go back to your regular schedule.
Do not take 2 doses at once.
Possible Side Effects
When adverse reactions occur, they are most commonly of the hypersensitivity
type such as skin rashes, urticaria, erythema multiform-like drug reactions,
and rarely, angioneurotic edema, and may necessitate withdrawal of therapy
and appropriate countermeasures. Paresthesias of the hands and feet have
been reported rarely after extended therapy. Other side effects reported
occasionally are oral thrush, nausea, vomiting, epigastria distress, diarrhea,
headache, fatigue, dizziness, insomnia, mental confusion, and impairment
of performance of routine activities. Administration of the drug should be
discontinued if granulocytopenia occur. When rare, serious reactions occur
with Gris-PEG, they are usually associated with high dosages, long periods
of therapy, or both.
Overdose
Any medication taken in excess can have dangerous consequences. If you suspect
an overdose of Gris-PEG, seek emergency medical treatment immediately.
More Information
Gris-PEG may intensify the effects of alcohol. If you drink alcohol while
taking this medication, your heart may start beating faster and your skin
may be flushed. If Gris-PEG is taken with certain other drugs, the effects
could be increased, decreased, or altered. It is especially important to
check with your doctor before combining Gris-PEG with the following:
Blood-thinning drugs such as Coumadin, Barbiturates such as Phenobarbital,
Oral Contraceptives.
Disclaimer
This drug information is for your information purposes only, it is not intended
that this information covers all uses, directions, drug interactions,
precautions, or adverse effects of your medication. This is only general
information, and should not be relied on for any purpose. It should not be
construed as containing specific instructions for any particular patient.
We disclaim all responsibility for the accuracy and reliability of this
information, and/or any consequences arising from the use of this information,
including damage or adverse consequences to persons or property, however
such damages or consequences arise. No warranty, either expressed or implied,
is made in regards to this information. |